About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Houston | 206 Studies

Clinical Trials Kidney DiseaseHouston

Kidney Disease Clinical Trials in Houston

Find 206 clinical trials for kidney disease near Houston, Texas. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 206 trials

TerminatedStudy of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) NephropathyThe primary objective of this study is to evaluate the effect of OMS721 on 24-hour urine protein excretion (UPE) in IgA nephropathy (IgAN) patients with high baseline proteinuria…NCT03608033·Florence, Alabama and 138 others

Kidney Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinThe purpose of the study is to determine the long-term safety in treatment-emergent adverse events (TEAEs) of intravenous (IV) administration of Epoetin Hospira for maintenance of…NCT01628107·Azusa, California and 109 others

Active not recruitingProact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseThe purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.NCT05099770·Huntsville, Alabama and 87 others

RecruitingImplementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.NCT06906627·Birmingham, Alabama and 6 others

TerminatedA Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseThe purpose of the study is to evaluate the dose-response efficacy, safety, and pharmacokinetics (PK) of AZD5718 in participants with proteinuric chronic kidney disease.NCT04492722·Canoga Park, California and 110 others

TerminatedSevere Renal Disease Study in Fabry Patients Treated With FabrazymeThis study was designed to determine appropriate treatment with Fabrazyme at a biweekly dose of either 1 mg/kg or 3 mg/kg in a population of patients with severe renal disease…NCT00837824·Farmington, Connecticut and 8 others

RecruitingStudy to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseThis study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney disease.NCT07271186·Huntsville, Alabama and 57 others

CompletedAdvancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluating the graft function of everolimus and reduced CNI versus MPA and standard CNI in adult de novo renal…NCT01950819·Birmingham, Alabama and 183 others

CompletedSafety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic HemodialysisThe purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of…NCT01503021·Mobile, Alabama and 30 others

Active not recruitingEASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study.NCT06531824·Huntsville, Alabama and 560 others

CompletedStudy Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell DiseaseThe goal of the study was to evaluate descriptively the effect of crizanlizumab + standard of care and standard of care alone on renal function in sickle cell disease patients ≥…NCT04053764·Birmingham, Alabama and 23 others

CompletedStudy to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisApproximately 207 patients with chronic kidney disease (CKD) on hemodialysis will be entered into this study at approximately 26 centers in the United States.NCT00268957·Birmingham, Alabama and 28 others

CompletedSafety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on DialysisThe purpose of the study is to evaluate the safety and efficacy of roxadustat for treatment of anemia in patients with chronic kidney disease not on dialysisNCT02174627·Birmingham, Alabama and 358 others

CompletedStudy of Phosphate Levels in Patients With Chronic Kidney DiseaseThe purpose of this study is to investigate the ability of different doses of PA21 to lower serum phosphate levels, in patients with chronic kidney disease on maintenance…NCT00824460·Arvada, Colorado and 59 others

CompletedStudy of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With AnemiaThe primary purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with non-dialysis chronic kidney disease.NCT01244763·Mobile, Alabama and 37 others

RecruitingFerric Citrate and Chronic Kidney Disease in ChildrenWe will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23…NCT04741646·Los Angeles, California and 19 others

CompletedStudy of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin AlfaThis is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) study to evaluate oral Vadadustat for the treatment of anemia in hemodialysis…NCT03799627·Fresno, California and 40 others

CompletedSafety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney DiseaseDS-5565 (mirogabalin) is being studied as treatment for fibromyalgia (FM) pain.NCT02496884·Phoenix, Arizona and 38 others

CompletedSafety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisThe purpose of this study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.NCT00597584·Phoenix, Arizona and 83 others

CompletedA Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskThe main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes and obesity or overweight at…NCT05803421·Daphne, Alabama and 357 others

PreviousPage 4 of 11Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia